AI Generated Image
Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
Reuters • • business
Key Points:
- Boston Scientific experienced a network outage caused by unauthorized activity on its IT systems, disrupting manufacturing and order processing since August 25, with the full financial impact still uncertain.
- The company expects to recover some lost revenue as operations ramp up and backlogs are addressed, with major distribution and manufacturing facilities now operating at or above normal levels.
- Analysts express concern over 2026 being viewed as a "lost year" for Boston Scientific, with the cyberattack complicating visibility into the company's business trends and delaying investor assessment of key product franchises.
- Boston Scientific had previously forecasted 2026 adjusted earnings of $3.28 to $3.32 per share and sales growth of 5.5% to 6.5%, but shares fell 2.3% following the outage news.
- The company plans to provide an updated financial outlook when it reports third-quarter results on October 28.
